
AdvaMed Comment Letter to OIG’s RFI on Clinical Trial Remuneration and Fraud & Abuse Laws
AdvaMed urges OIG to modernize Anti-Kickback Statute and Beneficiary Inducements CMP rules with a clinical trial-specific safe harbor to provide greater clarity for reasonable participant remuneration and support arrangements.














